Medical Oncology

, Volume 15, Issue 1, pp 6–14 | Cite as

Primary fallopian tube cancer: a review of the literature

  • Ann-Cathrin Hellström


Oncol Human Papilloma Virus Obstet Gynecol Epithelial Ovarian Cancer Fallopian Tube 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Doran A. An unreported case of primary cancer of the Fallopian tubes in 1847, with notes on primary tubal cancer.Transactions of the Obstetrical Society, London 1896;38: 322–326.Google Scholar
  2. 2.
    Southwood WFW. Carcinoma of the uterine tube. A review and a description of a case with unusual clinical features, presenting as an acute abdominal emergency.Br J Surg 1956;44: 487–489.CrossRefGoogle Scholar
  3. 3.
    Nordin AJ. Primary carcinoma of the fallopian tube. A 20-year literature review.Obstetrical and Gynecological Survey 1994;49(5): 349–361.PubMedCrossRefGoogle Scholar
  4. 4.
    Hellström A-Cet al. Carcinoma of the fallopian tube. A clinical and histopathological review. The Radiumhemmet series.Int J Gynecol Cancer 1994;4: 395–400.PubMedCrossRefGoogle Scholar
  5. 5.
    Rose PG, Piver MS, Tsukada Y. Fallopian tube cancer.Cancer 1990;6: 2661–2667.CrossRefGoogle Scholar
  6. 6.
    Peters WAet al. Prognostic features of carcinoma of the fallopian tube.Obstet Gynecol 1988;1: 757–762.Google Scholar
  7. 7.
    Rosenblatt KA, Weiss NS, Schwartz SM. Incidence of malignant fallopian tube tumours.Gynecol Oncol 1989;35: 236–239.PubMedCrossRefGoogle Scholar
  8. 8.
    Pfeiffer Pet al. Primary carcinoma of the Fallopian tube.Acta Oncol 1989;28: 7–11.PubMedCrossRefGoogle Scholar
  9. 9.
    Pettersson F (ed).FIGO Annual Report. Vol 22, Stockholm, 1995.Google Scholar
  10. 10.
    Robey SS, Silva EG. Epithelial hyperplasia of the fallopian tube. Its association with serous borderline tumours of the ovary.Int J Gynecol Pathol 1989;8: 214–220.PubMedGoogle Scholar
  11. 11.
    Heselmeyer Ket al. Primary fallopian tube: comparative genomic, hybridisation reveals high genetic instability and a specific, recurring pattern of chromosomal aberrations.Int J Genecol Pathol 1997; in press.Google Scholar
  12. 12.
    Vinall PS, Buxton N. Primary carcinoma of the fallopian tube associated with tuberculous salpingitis. A case report.Br J Obstet Gynaecol 1979;86: 984–989.PubMedGoogle Scholar
  13. 13.
    Yoonessi M, Leberer JP, Crickard K. Primary fallopian tube carcinoma: treatment and spread pattern.J Surg Oncol 1998;39: 97–100.Google Scholar
  14. 14.
    Plentl A, Friedman E. Lymphatics of the fallopian tube. In: Plentl ALymphatic System of the Female Genitalia Saunders: Philadelphia, 1971; pp 153–167Google Scholar
  15. 15.
    Tamimi H, Figge D. Adenocarcinoma of the uterine tube: potential for lymph node metastases.Am J Obstet Gynecol 1981;141: 132–137.PubMedGoogle Scholar
  16. 16.
    Di Re Eet al. Fallopian tube cancer: incidence and role of lymphatic spread.Gynecol Oncol 1996;62: 199–202.PubMedCrossRefGoogle Scholar
  17. 17.
    Klein Met al. Lymphogenous metastasis in the primary carcinoma of the fallopian tube.Gynecol Oncol 1994;55: 336–338.PubMedCrossRefGoogle Scholar
  18. 18.
    Harrison CR, Averette HE, Jarrell MA. Carcinoma of the fallopian tube: clinical management.Gynecol Oncol 1989;32: 357–359.PubMedCrossRefGoogle Scholar
  19. 19.
    Semrad Net al. Fallopian tube adenocarcinom: common extraperitoneal recurrence.Gynecol Oncol 1986;24: 230–235.PubMedCrossRefGoogle Scholar
  20. 20.
    Hu C, Taymor M, Hertig A. Primary carcinoma of the fallopian tube.Am J Obstet Gynecol 1950;59: 58–67.PubMedGoogle Scholar
  21. 21.
    Moore DHet al. Adenosquamous carcinoma of the fallopian tube.Am J Obstet Gynecol 1987;157(4): 903–905.PubMedGoogle Scholar
  22. 22.
    Rorat E, Wallack RC. Endometrioid carcinoma of the fallopian tube: pathology and clinical outcome.Int J Gynecol Oncol 1990;32: 163–167.CrossRefGoogle Scholar
  23. 23.
    Halligan AWF. Malignant fibrous histiocytoma of the fallopian tube.Br J Obst Gynaecol 1990;97: 275–276.Google Scholar
  24. 24.
    Hellström A-Cet al. Prognostic factors in malignant mixed Müllerian tumour of the fallopian tube: the Radiumhemmet series 1923–1994.Int J Gynecol Cancer 1996;6: 467–472.CrossRefGoogle Scholar
  25. 25.
    Sedlis A. Carcinoma of the fallopian tube.Surg Clin North Amer 1978;58: 121–129.Google Scholar
  26. 26.
    Sanger M, Barth J. Die Neubildungen der Eileiter. In: Martin A (ed).Die Krankheiten der Eileiter Leipzig, 1985.Google Scholar
  27. 27.
    Tharmaseelan NKS, Sundralingam S. Primary adenocarcinoma of the fallopian tube: a case report.Med J Malaysia 1989;44: 354–356.PubMedGoogle Scholar
  28. 28.
    Kimmel KDet al. Fallopian tube cancer.Am Fam Physician 1988;38(5): 121–124.PubMedGoogle Scholar
  29. 29.
    Roberts JA, Lifshitz S. Primary adenocarcinoma of the fallopian tube.Gynecol Oncol 1982;13: 301–318.PubMedCrossRefGoogle Scholar
  30. 30.
    Benedet JLet al. Adenocarcinoma of the fallopian tube.Obstet Gynecol 1977;50: 654–657.PubMedGoogle Scholar
  31. 31.
    McMurray EHet al. Carcinoma of the fallopian tube. Management and sites of failure.Cancer 1986;5: 2070–2075.CrossRefGoogle Scholar
  32. 32.
    Muntz HGet al. Primary adenocarcinoma of the fallopian tube.Eur J Gynaecol Oncol 1989;10: 239–249.PubMedGoogle Scholar
  33. 33.
    Podratz Ket al. Primary carcinoma of the Fallopian tube.Obstet Gynecol 1986;154: 1319–1326.Google Scholar
  34. 34.
    Denham JW, MacLennan KA. The management of primary carcinoma of the fallopian tube.Cancer 1984;53: 166–172.PubMedCrossRefGoogle Scholar
  35. 35.
    Eddy Get al. Fallopian tube carcinoma.Obstet Gynecol 1984;64: 546–552.PubMedGoogle Scholar
  36. 36.
    Yoonessi M. Carcinoma of the fallopian tube.Obstet Gynecol Surg 1979;34: 257–270.Google Scholar
  37. 37.
    Ajjimakorn S, Bhamarapravati Y, Israngura N. Ultrasound appearance of the fallopian tube carcinoma.J Clin Ultrasound 1988;1: 516–518.CrossRefGoogle Scholar
  38. 38.
    Timor-Tritsch I, Rottem S. Transvaginal ultrasonographic study of the fallopian tube.Obstet Gynecol 1987;70: 424–428.PubMedGoogle Scholar
  39. 39.
    Subramanyam Bet al. Ultrasonic features of fallopian tube carcinoma.J Ultrasound Med 1984;3: 391–393.PubMedGoogle Scholar
  40. 40.
    Granberg S, Jansson I. Early detection of primary carcinoma of the fallopian tube by endovaginal ultrasound.Acta Obstet Gynecol Scand 1990;69: 667–668.PubMedCrossRefGoogle Scholar
  41. 41.
    Kol Set al. Preoperative diagnosis of fallopian tube carcinoma by transvaginal sonography and CA-125.Gynecol Oncol 1990;37: 129–131.PubMedCrossRefGoogle Scholar
  42. 42.
    O'Conell Get al. Predective value of CA 125 for ovarian carcinoma in patients presenting with pelvic masses.Obstet Gynecol 1987;70: 930–932.Google Scholar
  43. 43.
    Malkasian Get al. Preoperative evaluation of serum CA 125 levels in premenopausal and postmenopausal patients with pelvic masses; discrimination of benign from malignant disease.Am J Obstet Gynecol 1988;159: 341–346.PubMedGoogle Scholar
  44. 44.
    Rosén ACet al. Preoperative and postoperative CA-125 serum levels in primary Fallopian tube carcinoma.Arch Gynecol Obstet 1994;255: 65–68.PubMedCrossRefGoogle Scholar
  45. 45.
    Kawakami Set al. Primary malignant tumour of the Fallopian tube: appearance at CT and MR imaging.Radiology 1993;186: 503–508.PubMedGoogle Scholar
  46. 46.
    Gurney H, Murphy D, Crowther D. The management of primary fallopian tube carcinoma.Br J Obstet Gynaecol 1990;97(9): 822–826.PubMedGoogle Scholar
  47. 47.
    Dodson M, Ford J Jr, Averett H. Clinical aspects of fallopian tube carcinoma.Obstet Gynecol 1970;36: 935–939.PubMedGoogle Scholar
  48. 48.
    Erez S, Kaplan AL, Wall JA. Clinical staging of carcinoma of the uterine tube.Obstet Gynecol 1967;30: 547–550.PubMedGoogle Scholar
  49. 49.
    Momtazee S, Kempson RL. Primary adenocarcinoma of the fallopian tube.Obstet Gynecol 1968;32: 649–656.PubMedGoogle Scholar
  50. 50.
    Schiller H, Silverberg S. Staging and prognosis in primary carcinoma of the fallopian tube.Cancer 1971;28: 389–395.PubMedCrossRefGoogle Scholar
  51. 51.
    Pettersson F. Staging rules for gestational trophoblastic tumours and fallopian tube cancer.Acta Obstet Gynecol Scand 1992;71: 224–225.PubMedCrossRefGoogle Scholar
  52. 52.
    Barakat Ret al. Cisplatin-based combination chemotherapy in carcinoma of the fallopian tube.Gynecol Oncol 1991;42: 156–160.PubMedCrossRefGoogle Scholar
  53. 53.
    Tokunaga T, Miyazaki K, Okamura H. Pathology of the fallopian tube.Curr Opin Obstet Gynecol 1991;3: 574–579.PubMedGoogle Scholar
  54. 54.
    Schink JC, Lurain JR. Rare gynecologic malignancies.Curr Opin Obstet Gynecol 1991;3: 78–90.PubMedGoogle Scholar
  55. 55.
    Fedele Let al. Successfulin vitro fertilisation and embryo transfer after limited surgical treatment for tubal adenocarcinoma.Cancer 1989;64(2): 1546–1547.PubMedCrossRefGoogle Scholar
  56. 56.
    Pectasides Det al. Treatment of primary Fallopian tube carcinoma ith cis-platin-containing chemotherapy.Am J Clin Oncol (CCT) 1994;17(1): 68–71.CrossRefGoogle Scholar
  57. 57.
    Morris Met al. Treatment of fallopian tube carcinoma with cisplatin, doxorubicin, and cyclophosphamide.Obstet Gynecol 1990;76: 1020–1023.PubMedGoogle Scholar
  58. 58.
    Cormio Get al. Treatment of Fallopian tube carcinoma with cyclophosphamide, adriamycin, and cisplatin.Am J Clin Oncol (CCT) 1997;20(2): 143–145.CrossRefGoogle Scholar
  59. 59.
    Kinzel G. Primary carcinoma of the fallopian tube.Am J Obstet Gynecol 1976;125: 816–820.PubMedGoogle Scholar
  60. 60.
    Rosén ACet al. A comparative analysis of management and prognosis in stage I and stage II Fallopian tube carcinoma and epithelial ovarian cancer.Br J Cancer 1994;69: 577–579.PubMedGoogle Scholar
  61. 61.
    Henderson SR, Haper RC, Salzar OM. Primary carcinoma of the fallopian tube.Gynecol Oncol 1977;5: 168–179.PubMedCrossRefGoogle Scholar
  62. 62.
    Schray MF, Podratz KC, Malkasian GD. Fallopian cancer: the role of radiation therapy.Radiother Oncol 1987;10: 267–275.PubMedCrossRefGoogle Scholar
  63. 63.
    Singhai Set al. Role of radiotherapy in the management of primary carcinoma of the fallopian tube.Indian J Med Sci 1991;45: 58–60.Google Scholar
  64. 64.
    Phelps HM, Chapman KE. Role of radiation therapy in treatment of primary carcinoma of the uterine tube.Obstet Gynecol 1974;43: 669–673.PubMedGoogle Scholar
  65. 65.
    Muntz Het al. Combination chemotherapy in advanced adenocarcinoma of the fallopian tube.Gynecol Oncol 1991;40: 268–273.PubMedCrossRefGoogle Scholar
  66. 66.
    Johnston GA. Primary malignancy of the fallopian tube. A clinical review of 13 cases.J Surg Oncol 1983;24(4): 304–309.PubMedCrossRefGoogle Scholar
  67. 67.
    Klein Met al. Evaluation of adjuvant therapy after surgery for primary carcinoma of the Fallopian tube.Arch Gynecol Obstet 1994;255: 19–24.PubMedCrossRefGoogle Scholar
  68. 68.
    Klein Met al. Primary Fallopian tube carcinoma—a retrospective survey of 51 cases.Arch Gynecol Obstet 1994;255: 141–146.PubMedCrossRefGoogle Scholar
  69. 69.
    Rosén ACet al. Prognostic factors in primary fallopian tube carcinoma.Gynecol Oncol 1994;53: 307–313.PubMedCrossRefGoogle Scholar
  70. 70.
    Bast RC, Klug TL, St John E. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer.N Engl J Med 1983;309: 883–887.PubMedCrossRefGoogle Scholar
  71. 71.
    Einhorn Net al. Preoperative evaluation of serum-CA-125 levels in patients with primary epithelial ovarian cancer.Obstet Gynecol 1986;67: 414–416.PubMedGoogle Scholar
  72. 72.
    Makar APHet al. Serum CA-125 as a tumor marker and the expression of c-erB-2 oncogene in tubal malignancies.Int J Gyncol Cancer 1993;3: 116–121.CrossRefGoogle Scholar
  73. 73.
    Tokunaga Tet al. Serial measurement of CA 125 in patients with primary carcinoma of the fallopian tube.Gyn Oncol 1990;36: 335–337.CrossRefGoogle Scholar
  74. 74.
    Davies APet al. Raised serum CA 125 preceding the diagnosis of carcinoma of the fallopian tube two case reports.British J of Obstetrics and Gynecol 1991;98: 602–603.Google Scholar
  75. 75.
    Kawabat SEet al. Immunopathologic characterisation of a monoclonal antibody that recognises common surface antigens of human ovarian tumours of serous, endometrioid and clear cell types.Amer J Clin Pathol 1983;79: 58–64.Google Scholar
  76. 76.
    Neunteufel W, Breitenecker G. Tissue expression of CA 125 in benign and malignant lesions of ovary and fallopian tube. A comparison with CA 19-9 and CEA.Gynecol Oncol 1989;32: 297–302.PubMedCrossRefGoogle Scholar
  77. 77.
    Rosén ACet al. DNA-ploidy in primary fallopian tube carcinoma using image cytometry.Int J Cancer 1994;58: 362–365.PubMedCrossRefGoogle Scholar
  78. 78.
    Hellström A-Cet al. DNA-ploidy and mutant p53 overexpression in primary fallopian tube cancer.Int J Gynecol Cancer 1994;4: 408–413.PubMedCrossRefGoogle Scholar
  79. 79.
    Hellström A-Cet al. Primary fallopian tube carcinoma: the prognostic impact of stage, histopathology, and biological parameters.Int J Gynecol Cancer 1996;6: 456–462.CrossRefGoogle Scholar
  80. 80.
    Runnebaum IBet al. p53 mutation is associated wit high S-phase fraction in primary fallopian tube adenocarcinoma.Br J Cancer 1996;74: 1157–1160.PubMedGoogle Scholar
  81. 81.
    Lacy MQet al.C-erb B-2 and p53 expression in fallopian tube carcinoma.Cancer 1995;75: 2891–2896.PubMedCrossRefGoogle Scholar
  82. 82.
    Heselmeyer Ket al. Advanced-stage cervical carcinomas are defined by a recurrent pattern of chromosomal aberrations revealing high genetic instability and a consistent gain of chromosome arm 3q.Genes Chromosome Cancer 1997;19: 233–240.CrossRefGoogle Scholar
  83. 83.
    Navani SSet al. Endometrioid carcinoma of the Fallopian tube: a clinopathologic analysis of 26 cases.Gynecol Oncol 1996;63: 371–378.PubMedCrossRefGoogle Scholar

Copyright information

© Stockton Press All rights reserved 1998

Authors and Affiliations

  • Ann-Cathrin Hellström
    • 1
  1. 1.Department of Gynaecological Oncology, RadiumhemmetKarolinska Institute and HospitalStockholmSweden

Personalised recommendations